EXPERIMENTALLY-INDUCED LATE-ONSET MUCOSAL DISEASE - CHARACTERIZATION OF THE CYTOPATHOGENIC VIRUSES ISOLATED

Citation
J. Fritzemeier et al., EXPERIMENTALLY-INDUCED LATE-ONSET MUCOSAL DISEASE - CHARACTERIZATION OF THE CYTOPATHOGENIC VIRUSES ISOLATED, Veterinary microbiology, 46(1-3), 1995, pp. 285-294
Citations number
21
Categorie Soggetti
Microbiology,"Veterinary Sciences
Journal title
ISSN journal
03781135
Volume
46
Issue
1-3
Year of publication
1995
Pages
285 - 294
Database
ISI
SICI code
0378-1135(1995)46:1-3<285:ELMD-C>2.0.ZU;2-S
Abstract
Antigenic and genetic analyses were performed in order to establish re lationships between the noncytopathogenic (ncp) and the cytopathogenic (cp) bovine viral diarrhoea viruses (BVDV) involved in the induction of a case of experimentally induced ''late-onset'' mucosal disease (MD ) symptoms. The persistent ncpBVDV, the cpBVDV used for superinfection (strain TGAC) and the virus isolates from faeces (cpX) were examined using an immunoplaque test (IPT) to distinguish between cp and ncp vir us populations. The cp populations were cloned by plaque purification and found to be free of ncpBVDV when using the IPT. The cpBVDV clones and the persistent ncpBVDV were analysed in an enzyme immunoassay on h eat-fixed infected cells (IM-EIA) and in a neutralization test using a panel of 27 monoclonal antibodies against the E0 (gp48) and E2 (gp53) viral glycoproteins. It was found that strain TGAC contained two anti genically distinct subpopulations of cpBVDV (TGAC-B1 and TGAC-B2). The endogenous ncpBVDV and the cpX clones had the same reactivity pattern in both tests. In addition, p80 gene duplications in the genomes of t he cpBVDV clones were analysed using the polymerase chain reaction and subsequent restriction enzyme analysis of the amplicons. The clones a nalysed from TGAC-B1 and those from cpX had gene duplications of ident ical sizes showing the same restriction enzyme patterns. Our results s uggest that the cpBVDV which finally lead to ''late-onset'' MD arose b y recombination and/or by mutations of the cpBVDV used for superinfect ion.